5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected RecipientsHCVRecruitingNot applicable2026-09-04NCT05653232
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in PregnancyApnea, Female Urogenital Diseases and Pregnancy Complications, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder, respiratory system disorderActive, not recruitingNot applicable2026-08-05NCT03487185
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With PhenylketonuriaBrain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuriaActive, not recruitingPhase 32026-07-21NCT05270837
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery TrialDeath, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Urogenital Diseases, pregnancy disorder, pregnancy disorder with abortive outcomeRecruitingPhase 32026-04-09NCT06980025
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epistaxis, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, anemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformationActive, not recruitingPhase 2 / Phase 32026-03-19NCT03850964